We will never make medicine affordable if how to tie a drug’s price to its value is solely determined by the companies creating the drugs.
Related stories
Drone stocks are soaring thanks to Trump’s new tariffs
Why is Selena Gomez being sued?
Kraken Parent Payward Posts $508M Q2 Revenue, Up 17% Year Over Year
OpenAI Just Hit a $40 Billion Run Rate. So Why Are Its Top Executives Sprinting for the Exit Before the IPO?
C3.ai Remains Turbulent: Why One Of Wall Street’s Most Outspoken Pros Expects 50% Returns From Here
S&P Slips Back From Records